Global COVID-19 Diagnostic Testing Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Nucleic Acid Testing
- 1.2.3 Antibody Testing
- 1.3 Market by Application
- 1.3.1 Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2026
- 1.3.2 Hospitals
- 1.3.3 Scientific Research
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global COVID-19 Diagnostic Testing Market Perspective (2015-2026)
- 2.2 Global COVID-19 Diagnostic Testing Growth Trends by Regions
- 2.2.1 COVID-19 Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 COVID-19 Diagnostic Testing Historic Market Share by Regions (2015-2020)
- 2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top COVID-19 Diagnostic Testing Players by Market Size
- 3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2015-2020)
- 3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2015-2020)
- 3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
- 3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
- 3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2019
- 3.5 Key Players COVID-19 Diagnostic Testing Area Served
- 3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
- 3.7 Date of Enter into COVID-19 Diagnostic Testing Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type (2015-2026)
- 4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2015-2020)
- 4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2021-2026)
5 COVID-19 Diagnostic Testing Breakdown Data by Application (2015-2026)
- 5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2015-2020)
- 5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America COVID-19 Diagnostic Testing Market Size (2015-2026)
- 6.2 North America COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
- 6.3 North America COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
- 6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe COVID-19 Diagnostic Testing Market Size (2015-2026)
- 7.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
- 7.3 Europe COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
- 7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China COVID-19 Diagnostic Testing Market Size (2015-2026)
- 8.2 China COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
- 8.3 China COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
- 8.4 China COVID-19 Diagnostic Testing Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan COVID-19 Diagnostic Testing Market Size (2015-2026)
- 9.2 Japan COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
- 9.3 Japan COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
- 9.4 Japan COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia COVID-19 Diagnostic Testing Market Size (2015-2026)
- 10.2 Southeast Asia COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
- 10.3 Southeast Asia COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
- 10.4 Southeast Asia COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Cellex
- 11.1.1 Cellex Company Details
- 11.1.2 Cellex Business Overview
- 11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
- 11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2015-2020))
- 11.1.5 Cellex Recent Development
- 11.2 Abbott
- 11.2.1 Abbott Company Details
- 11.2.2 Abbott Business Overview
- 11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
- 11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.2.5 Abbott Recent Development
- 11.3 Roche
- 11.3.1 Roche Company Details
- 11.3.2 Roche Business Overview
- 11.3.3 Roche COVID-19 Diagnostic Testing Introduction
- 11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.3.5 Roche Recent Development
- 11.4 BioMedomics
- 11.4.1 BioMedomics Company Details
- 11.4.2 BioMedomics Business Overview
- 11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
- 11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.4.5 BioMedomics Recent Development
- 11.5 BD
- 11.5.1 BD Company Details
- 11.5.2 BD Business Overview
- 11.5.3 BD COVID-19 Diagnostic Testing Introduction
- 11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.5.5 BD Recent Development
- 11.6 Henry Schein
- 11.6.1 Henry Schein Company Details
- 11.6.2 Henry Schein Business Overview
- 11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
- 11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.6.5 Henry Schein Recent Development
- 11.7 Safecare Bio-Tech
- 11.7.1 Safecare Bio-Tech Company Details
- 11.7.2 Safecare Bio-Tech Business Overview
- 11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
- 11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.7.5 Safecare Bio-Tech Recent Development
- 11.8 Mayo Clinic Laboratories
- 11.8.1 Mayo Clinic Laboratories Company Details
- 11.8.2 Mayo Clinic Laboratories Business Overview
- 11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
- 11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.8.5 Mayo Clinic Laboratories Recent Development
- 11.9 Chembio Diagnostics
- 11.9.1 Chembio Diagnostics Company Details
- 11.9.2 Chembio Diagnostics Business Overview
- 11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
- 11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.9.5 Chembio Diagnostics Recent Development
- 11.10 Mount Sinai Laboratory
- 11.10.1 Mount Sinai Laboratory Company Details
- 11.10.2 Mount Sinai Laboratory Business Overview
- 11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
- 11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 11.10.5 Mount Sinai Laboratory Recent Development
- 11.11 Ortho Clinical Diagnostics
- 10.11.1 Ortho Clinical Diagnostics Company Details
- 10.11.2 Ortho Clinical Diagnostics Business Overview
- 10.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
- 10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.11.5 Ortho Clinical Diagnostics Recent Development
- 11.12 Zhejiang Orient Gene Biotech
- 10.12.1 Zhejiang Orient Gene Biotech Company Details
- 10.12.2 Zhejiang Orient Gene Biotech Business Overview
- 10.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
- 10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.12.5 Zhejiang Orient Gene Biotech Recent Development
- 11.13 Innovita Biological Technology
- 10.13.1 Innovita Biological Technology Company Details
- 10.13.2 Innovita Biological Technology Business Overview
- 10.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
- 10.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.13.5 Innovita Biological Technology Recent Development
- 11.14 Guangzhou Wondfo Biotech
- 10.14.1 Guangzhou Wondfo Biotech Company Details
- 10.14.2 Guangzhou Wondfo Biotech Business Overview
- 10.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
- 10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.14.5 Guangzhou Wondfo Biotech Recent Development
- 11.15 Guangdong Hecin-Scientific
- 10.15.1 Guangdong Hecin-Scientific Company Details
- 10.15.2 Guangdong Hecin-Scientific Business Overview
- 10.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
- 10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.15.5 Guangdong Hecin-Scientific Recent Development
- 11.16 Dynamiker Biotechnology (Tianjin)
- 10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
- 10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
- 10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
- 10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
- 11.17 ADVAITE
- 10.17.1 ADVAITE Company Details
- 10.17.2 ADVAITE Business Overview
- 10.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
- 10.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
- 10.17.5 ADVAITE Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
COVID-19 Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Nucleic Acid Testing
Antibody Testing
Market segment by Application, split into
Hospitals
Scientific Research
Based on regional and country-level analysis, the COVID-19 Diagnostic Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global COVID-19 Diagnostic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)